Orelabrutinib(1655504-04-3)
- Name: Orelabrutinib
- Synonyms:Orelabrutinib;1655504-04-3;ICP-022;ICP022;Orelabrutinib [INN];Orelabrutinib [USAN];WJA5UO9E10;6-[1-(1-Oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-3-pyridinecarboxamide;6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide;2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpiperidin-4-yl)pyridine-3-carboxamide;3-Pyridinecarboxamide, 6-(1-(1-oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-;6-(1-(1-Oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-3-pyridinecarboxamide;INNOBRUKA;UNII-WJA5UO9E10;Orelabrutinib [USAN:INN];ORELABRUTINIB [WHO-DD];CHEMBL4650321;SCHEMBL16597834;US9951056, Example 3;GTPL10629;ICP-022ICP-022;MZPVEMOYADUARK-UHFFFAOYSA-N;BDBM389631;EX-A3442;NSC826039;s9600;WHO 11190;AKOS040733921;NSC-826039;example 3 [WO2015048662A2];AC-36680;MS-27554;HY-129390;CS-0105163;F88710
- Molecular Formula:C26H25N3O3
- Molecular Weight:427.5
- CAS Registry Number:1655504-04-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1655504-04-3 99% up by HPLC Orelabrutinib 1655504-04-3
Assay:99% up by HPLC Application:API
Min. Order:0
Supplier:Sinoway Industrial Co., Ltd. [
China (Mainland)] CAS No.1655504-04-3 99% Orelabrutinib CAS 1655504-04-3 with Best Price
Assay:99% Appearance:white powder Package:foil bag or as your requirement Storage:2-8掳C Transportation:By Express, by air, by sea Application:Medical use
Min. Order:1Kilogram
Supplier:Hubei Yuanmeng Biological Technology Co., Ltd. [
China (Mainland)] CAS No.1655504-04-3 Orelabrutinib CAS No.1655504-04-3
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)] CAS No.1655504-04-3 Orelabrutinib
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 898751-61-6/Ethyl 8-[2-(morpholinomethyl)phenyl]-8-oxooctanoate
- 1000340-08-8/Ethyl 5-fluoro-4-hydroxy-6-oxo-1,6-dihydropyridine-3-carboxylate
- 1955474-88-0/4-oxo-4-[(1S,5S)-8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl]butanoic acid
- 1346446-95-4/5-fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine-4-carbonitrile
- 1447607-70-6/Ethyl 2-cyclopropyl-3-oxo-4-phenylbutanoate
- 1244856-06-1/Trimethylsilyl perfluorononanoate
- 1002726-60-4/2,2-Dimethyl-7-nitro-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one
- 186320-21-8/2-(9H-fluoren-9-ylmethoxycarbonylamino)-3,3-dimethylbutanoic acid
- 56098-52-3/Piperidin-2-ylmethanamine dihydrochloride
- 1354706-45-8/Methyl 3-(1-isopropyl-3-methyl-1H-pyrazol-4-yl)propiolate
- 1361116-16-6/4-Methyl-3-(pyrrolidin-3-yl)-4H-1,2,4-triazole dihydrochloride
- 906673-43-6/4-(1-Hydroxy-1,3-dihydro-benzo[c][1,2]oxaborol-5-yloxy)-benzoic acid
- 1119449-71-6/3-{[(5-{[(3-Methylbutyl)amino]carbonyl}-1,2,4-oxadiazol-3-yl)methyl]thio}propanoic acid
- 1219976-45-0/3-Amino-4-chloro-N-[3-(dimethylamino)propyl]-benzenesulfonamide hydrochloride
- 1160250-99-6/5-Bromo-2-[(3-methylbenzyl)oxy]benzoyl chloride
- 1187830-92-7/6-Chloropyridine-3,4-diamine hydrochloride
- 55899-31-5/Ethyl 4-iodopyrazolo[1,5-a]pyridine-3-carboxylate
- 1356931-03-7/CID 29973886
- 1346809-40-2/Ethyl 2-(4-aminopyridin-2-yl)-2-cyanoacetate
- 1655504-04-3/Orelabrutinib
- 1184913-95-8/5-amino-1-(tetrahydrofuran-3-yl)-1H-pyrazole-4-carboxamide
- 1160250-66-7/2-[(2-Chloro-4-fluorobenzyl)oxy]-3-methoxybenzoyl chloride
- 857629-71-1/4-(1,4-Dimethylpentyl)phenol
- 65386-69-8/2-bromo-N-(3,4-dimethoxy-11,11-dimethyl-15-oxo-5-propan-2-yl-16-oxatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6-trien-8-yl)propanamide
- 1232431-91-2/5-Chloro-4-phenylpyridin-2-amine
- 1173020-16-0/Semicarbazide-13C,15N2 Hydrochloride
- 956075-57-3/4-(1H-pyrazol-1-ylmethyl)piperidine
- 1363383-04-3/5-Bromo-1-methyl-7-nitro-1H-indazole
- 939990-02-0/3-Bromo-5-chloro-4-methylbenzonitrile
- 86753-15-3/Kefiran